ChartRow logo
VERX
$14.32+5.84%
as of close, Oct 20, 2026
☾ AH $14.32 +5.84%
PeersMUNVDASNDKAAPLAMDINTC
Share this page

VERX financial statements

The full income statement, balance sheet, and cash-flow statement for Vertex Inc. (VERX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2020-06 26.4M2026-06 162.2M+515.4% over 1 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue748M+12.2%667M+16.5%572M+16.4%492M+15.5%426M+13.6%
482M+13.0%426M+22.2%349M+16.8%298M+13.2%264M+26.0%
Cost of revenue267M+10.9%241M+7.5%224M+15.9%193M+19.3%162M-2.1%
479M+11.9%428M+17.0%366M+19.4%307M+15.0%267M-15.1%
Research & development83.7M+25.6%66.7M+14.5%58.2M+39.0%41.9M-4.9%44.0M-19.0%
Selling, general & administrative179M+16.9%153M+4.7%146M+20.0%122M+13.7%107M-28.2%
General & administrative179M+16.9%153M+4.7%146M+20.0%122M+13.7%107M-28.2%
Selling & marketing196M+15.2%171M+21.6%140M+11.9%125M+26.6%99.0M-0.4%
Amortization of intangibles2.28M-15.8%2.70M-6.3%2.88M-28.1%4.01M+276.5%1.07M+140.6%
Provision for credit losses2.54M+809.0%279K-86.8%2.11M+1193.3%-193K-142.5%454K+75.3%
Operating income2.33M+204.6%-2.23M+87.3%-17.5M-116.7%-8.08M-174.7%-2.94M+97.2%
Net interest income5.25M+26.9%4.14M+199.4%-4.16M-103.3%-2.05M-108.1%-984K
Other non-operating income
————-984K+68.4%
Gain (loss) on equity securities0.000.000.000.00—
Pre-tax income7.58M+297.0%1.91M+108.8%-21.7M-114.0%-10.1M-158.0%-3.93M+96.4%
Income tax368K-99.3%54.6M+736.7%-8.58M-494.7%2.17M+188.8%-2.45M+92.5%
Net income7.21M+113.7%-52.7M-302.7%-13.1M-6.4%-12.3M-731.9%-1.48M+98.0%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
561M+4.5%536M+101.2%267M+9.7%243M+24.3%196M-51.4%
Cash & equivalents314M+6.1%296M+334.3%68.2M-25.7%91.8M+25.2%73.3M-75.8%
Accounts receivable183M+11.6%164M+16.0%142M+37.8%103M+33.7%76.9M-0.3%
Prepaid expenses39.0M+6.2%36.7M+40.1%26.2M+17.2%22.3M+8.8%20.5M+54.9%
Other current assets———12.2M+47.5%8.29M+19.6%
1.27B+8.9%1.17B+53.5%760M+5.7%719M+7.3%670M+19.9%
Property, plant & equipment——89.0M-12.0%101M+4.5%96.7M+71.0%
Operating lease right-of-use9.68M-19.1%12.0M-18.1%14.6M-15.0%17.2M-15.1%20.2M
Goodwill392M+9.7%358M+38.8%258M+2.4%252M-6.7%270M+1553.8%
Long-term investments
15.0M————
Deferred tax assets85.0K+347.4%19.0K-100.0%41.7M+34.8%30.9M-12.4%35.3M+4.3%
Other non-current assets12.2M-13.0%14.1M-12.1%16.0M+4.4%15.3M+328.3%3.58M+9.7%
575M+6.9%537M+21.9%441M+9.3%403M+9.2%369M+26.4%
Accounts payable37.6M+3.7%36.2M+53.5%23.6M+64.7%14.3M+10.2%13.0M+46.5%
Accrued liabilities43.6M+24.1%35.2M-21.4%44.7M+17.0%38.2M+66.5%23.0M+19.8%
Deferred revenue383M+12.8%339M+17.0%290M+7.9%269M+13.3%237M+14.3%
Short-term & current debt——2.50M+14.3%2.19M—
Current lease liability4.28M+7.2%4.00M+7.5%3.72M-9.0%4.09M+3.9%3.93M
Finance lease liability (current)55.0K-28.6%77.0K+4.1%74.0K-28.2%103K-63.7%284K
1.01B+2.5%987M+94.8%507M+3.6%489M+11.2%440M+33.6%
Long-term debt337M+0.7%335M+660.8%44.1M-5.7%46.7M—
Deferred revenue (non-current)5.21M+7.6%4.84M+87.8%2.58M-75.0%10.3M-11.8%11.7M-20.7%
Non-current lease liability8.90M-29.3%12.6M-24.0%16.6M-18.9%20.4M-16.0%24.3M
Operating lease liability (total)13.2M-20.5%16.6M-18.3%20.3M-17.2%24.5M-13.3%28.3M
Finance lease liability (total)109K+25.3%87.0K-30.4%125K+10.6%113K-67.9%352K
Finance lease liability54.0K+440.0%10.0K-80.4%51.0K+410.0%10.0K-85.3%68.0K
Deferred tax liabilities5.66M-42.9%9.92M———
259M+44.4%179M-29.1%253M+10.1%230M-0.2%230M+0.3%
Additional paid-in capital316M+13.6%278M+1.2%275M+12.4%245M+10.0%223M+7.8%
Retained earnings-46.1M+13.5%-53.3M-8998.1%-586K-104.7%12.5M-49.6%24.8M-3.8%
Treasury stock
10.1M————
Accumulated other comprehensive income-1.37M+97.0%-45.9M-111.0%-21.7M+21.7%-27.8M-58.6%-17.5M-459.5%
Total equity incl. non-controlling—179M-29.1%253M+10.1%230M-0.2%230M+0.3%
Total liabilities & equity1.27B+8.9%1.17B+53.5%760M+5.7%719M+7.3%670M+19.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
166M+0.4%165M+121.7%74.3M+16.4%63.8M-29.3%90.3M+51.6%
Depreciation & amortization96.9M+17.2%82.7M+15.1%71.9M+17.6%61.2M+36.6%44.8M+39.0%
Intangible amortization2.28M-15.8%2.70M-6.3%2.88M-28.1%4.01M+276.5%1.07M+140.6%
Share-based compensation57.8M+21.8%47.4M+39.8%33.9M+71.9%19.7M-24.6%26.2M-82.3%
Deferred income taxes-5.39M-110.6%51.1M+541.2%-11.6M-760.5%-1.34M+56.8%-3.12M+90.7%
Change in receivables12.9M-41.7%22.1M-51.2%45.2M+76.2%25.7M+966.5%-2.96M-143.8%
Change in payables1.23M-89.5%11.6M+25.7%9.24M+575.0%1.37M-64.4%3.85M+308.8%
-124M+21.8%-158M-139.0%-66.2M+8.2%-72.0M+75.6%-295M-564.3%
Capital expenditure—71.8M+45.7%49.3M+8.2%45.5M+43.6%31.7M+51.3%
Free cash flow—93.1M+271.2%25.1M+36.9%18.3M-68.7%58.6M+51.8%
Acquisitions0.000.000.00-100.0%474K-99.8%251M+2073.0%
Sales/maturities of investments11.6M-30.5%16.7M-9.1%18.4M+242.8%5.36M—
-32.8M-114.2%231M+973.3%-26.5M-254.9%17.1M+287.9%-9.10M-104.3%
Long-term debt issued0.000.000.000.000.00-100.0%
Long-term debt repaid0.00-100.0%46.9M+2042.4%2.19M+133.3%938K0.00-100.0%
Common stock issued0.000.000.000.000.00-100.0%
Common stock repurchased10.1M0.000.000.000.00
Dividends paid0.000.000.000.000.00-100.0%
Other financing activities——-103K+92.4%-1.35M-40.5%-964K
FX effect on cash3.21M+417.5%-1.01M-239.8%724K+305.7%-352K+26.5%-479K-2077.3%
Net change in cash12.2M-94.8%237M+1446.3%-17.6M-306.0%8.54M+104.0%-214M-193.6%
Interest paid3.32M+0.9%3.29M-11.9%3.73M+67.9%2.22M+896.0%223K-90.9%
Income taxes paid1.92M-77.7%8.59M+52.0%5.65M+84.8%3.06M+137.7%1.29M+118.9%
Source filing10-K10-K10-K10-K10-K

About this data

Source: VERX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all VERX filings on SEC EDGAR → Not investment advice.